Immunology: Innate Immunity
Physical Barriers · Soluble Effectors · Cellular Phagocytosis
Overview: Host Defence Strategies
The vertebrate immune system is a highly sophisticated, evolutionary network designed to protect the host against foreign challenges and infections. The host defends itself against pathogens through three primary strategies:
- Strategy 1
AvoidancePreventing exposure to pathogens in the first place.
- Strategy 2
ResistanceReducing or eliminating pathogens once infection is established.
- Strategy 3
ToleranceEnhancing the host's capacity to resist tissue damage induced by pathogens.
Immunology is divided into two major, cooperative branches: innate (native) immunity and adaptive (acquired) immunity. This chapter covers the first and second lines of defence provided by the innate immune system.
1. Innate Immunity: First and Second Lines of Defence
Innate immunity is present from birth, is evolutionarily primitive, and provides a rapid, non-specific early defence against pathogens. It does not rely on previous exposure to a pathogen, operates without immunologic memory, and is found in almost all multicellular organisms. It relies on physical and chemical barriers, soluble effector molecules, cellular phagocytic mechanisms, and pattern recognition systems.
1.1 Physical and Chemical Barriers
These barriers represent the host's first line of defence, acting as an avoidance strategy to block pathogen entry.
Anatomical Barriers
The skin and mucous membranes (mucosa) block microbes from entering internal tissues. Mucous membranes entrap foreign organisms, and mucosal surfaces produce a variety of antimicrobial proteins that act as natural antibiotics.
Antimicrobial Proteins & Peptides
Generally less than 100 amino acids long, these molecules are secreted at epithelial surfaces:
- Protein
LysozymeAn enzyme found in saliva, tears, and respiratory tract fluids that actively cleaves the peptidoglycan components of bacterial cell walls.
- Protein
LactoferrinA protein that binds and sequesters essential metal ions (such as iron), preventing microbial growth.
- Peptide
DefensinsCysteine-rich cationic peptides (29–35 amino acid residues) that facilitate the killing of phagocytosed microbes.
- Microenvironment
Chemical BarriersThe acidic pH of sweat, sebaceous secretions, and gastric juice, along with hydrolytic enzymes, directly inhibits microbial growth.
1.2 Soluble Effector Molecules
If pathogens breach the physical and chemical barriers, soluble proteins in the blood and extracellular fluids provide immediate defence.
The Complement System
A group of over 30 serum proteins, primarily synthesised by the liver, circulating in inactive forms. Upon activation, they undergo a controlled enzymatic cascade that:
- Amplifies and complements the action of antibodies
- Bridges innate and adaptive immunity
- Clears immune complexes
- Targets pathogen membranes for lysis
Acute-Phase Proteins
A heterogeneous group of plasma proteins synthesised by the liver in response to microbial stimuli and inflammatory cytokines. They maximise complement activation and act as opsonins to enhance phagocytosis. Key examples:
- APP
C-reactive protein (CRP)Rises sharply during inflammation; enhances opsonisation and complement activation.
- APP
Serum amyloid protein A (SAA)An acute-phase reactant produced by the liver in response to inflammatory stimuli.
- APP
Mannose-binding protein (MBP)Recognises microbial surface carbohydrates and activates the lectin pathway of complement.
1.3 Cellular Mechanisms and Phagocytosis
The cellular components of the innate immune system — primarily neutrophils, macrophages, and dendritic cells — constitute the second line of defence. Phagocytosis is the active ingestion and destruction of foreign particulate matter.
Figure: Phagocytosis Pathway. Phagocytes recognise pathogens directly via surface receptors, or with enhanced efficiency through opsonisation by antibodies and complement. The pathogen is engulfed into a phagosome, which fuses with a lysosome to form a phagolysosome. Inside, the pathogen is destroyed by low pH, hydrolytic enzymes, and antimicrobial peptides, alongside a burst of toxic reactive oxygen and nitrogen species.
| Stage | Key Event | Mediators |
|---|---|---|
| Recognition & Opsonisation | Phagocyte surface receptors recognise microbial cell wall components; opsonins coat the pathogen | Antibodies, complement components |
| Engulfment | Pathogen internalised into a membrane-bound vesicle | Phagosome |
| Phagolysosome Formation | Phagosome fuses with a lysosome | Phagolysosome |
| Microbicidal Destruction | Pathogen killed inside the phagolysosome | Low pH, proteases, lysozymes, defensins, ROS, RNS |
Oxidative Burst
Phagocytosis triggers a massive consumption of oxygen, producing highly toxic Reactive Oxygen Species (ROS) — hydroxyl radicals, superoxide radicals, hydrogen peroxide — and Reactive Nitrogen Species (RNS) — nitric oxide, peroxynitrite — that damage microbial membranes and proteins.
2. Pattern Recognition Receptors (PRRs) and Toll-like Receptors (TLRs)
The innate immune system identifies pathogens using germline-encoded Pattern Recognition Receptors (PRRs) that detect highly conserved molecular structures.
2.1 Molecular Targets: PAMPs vs. DAMPs
- Exogenous
PAMPsPathogen-Associated Molecular Patterns: highly conserved, pathogen-specific molecular signatures essential for microbial survival. Examples include double-stranded RNA (dsRNA) of viruses, unmethylated CpG DNA sequences in bacteria, bacterial pilin and flagellin, lipopolysaccharide (LPS) in the outer membrane of Gram-negative bacteria, and lipoteichoic acid in Gram-positive cell walls.
- Endogenous
DAMPsDamage-Associated Molecular Patterns: endogenous molecules released from damaged, stressed, or dying host cells, signaling tissue damage.
2.2 Mammalian PRR Classes
Mammals possess several distinct classes of cellular and soluble PRRs:
Five Classes of PRRs
- Toll-like Receptors (TLRs): Transmembrane signaling receptors.
- RIG-I-like Receptors (RLRs): Intracellular sensors of viral RNA.
- Nod-like Receptors (NLRs): Intracellular sensors of microbial components and cellular stress.
- AIM2-like Receptors (ALRs): Intracellular sensors of cytosolic DNA.
- C-type Lectin Receptors (CLRs): Transmembrane receptors primarily binding carbohydrate moieties.
2.3 Toll-Like Receptor (TLR) Architecture and Ligands
TLRs were originally identified for their role in the embryonic development of Drosophila melanogaster (controlling dorso-ventral polarity) and adult fly fungal resistance. They are Type I integral transmembrane glycoproteins ranging from 700 to 1100 amino acids.
- N-terminal
Extracellular DomainContains 16 to 28 leucine-rich repeats (LRRs) arranged in a horseshoe shape, responsible for PAMP/DAMP ligand binding.
- C-terminal
Intracellular DomainContains a conserved Toll/IL-1 receptor (TIR) domain that initiates downstream signaling cascades.
TLRs are categorised by their subcellular localisation, which correlates with their ligand specificity:
| TLR Complex | Primary Ligands | Subcellular Localisation | Species Distribution / Notes |
|---|---|---|---|
| TLR2/TLR1 | Bacterial triacyl lipopeptides | Plasma Membrane | Heterodimer |
| TLR2 | Fungal phospholipomannan, bacterial peptidoglycans | Plasma Membrane | Homodimer |
| TLR2/TLR6 | Fungal zymosan, bacterial diacyl lipopeptides, lipoteichoic acid, GPI anchors (Trypanosoma cruzi) | Plasma Membrane | Heterodimer |
| TLR3 | Viral double-stranded RNA (dsRNA) | Endosome / Lysosome | Intracellular |
| TLR4 | Bacterial lipopolysaccharide (LPS), fungal mannan | Plasma Membrane | Homodimer |
| TLR5 | Bacterial flagellin | Plasma Membrane | Homodimer |
| TLR7 | Viral single-stranded RNA (ssRNA) | Endosome / Lysosome | Intracellular |
| TLR8 | Viral single-stranded RNA (ssRNA) | Endosome / Lysosome | Intracellular |
| TLR9 | Bacterial and viral CpG DNA, hemozoin (Plasmodium falciparum) | Endosome / Lysosome | Intracellular |
| TLR10 | Unknown | Plasma Membrane | Present in humans, absent in mice |
| TLR11 | Unknown | Endosome / Lysosome | Present in mice, absent in humans |
| TLR12 | Profilin (Toxoplasma gondii) | Endosome / Lysosome | Present in mice, absent in humans |
| TLR13 | Bacterial 23S rRNA | Endosome / Lysosome | Present in mice, absent in humans |
2.4 TLR Signaling Pathways
Ligand binding induces the dimerisation of TLRs (either as homodimers or heterodimers). This conformational change recruits specific cytoplasmic adaptor proteins to the TIR domain, initiating two primary signaling pathways.
Figure: TLR Signaling Pathways. TLR dimerisation recruits one of two adaptor proteins to the TIR domain. All TLRs except TLR3 signal through MyD88, driving a kinase cascade that activates NF-κB and the transcription of pro-inflammatory cytokines (IL-1, IL-6, TNF-α). TLR3 and endosomal TLR4 signal through TRIF, activating Interferon Regulatory Factors (IRF3/IRF7) to drive transcription of Type I interferons (IFN-α, IFN-β) and promote dendritic cell maturation.
MyD88-Dependent Pathway
Utilised by all TLRs except TLR3. Recruitment of the MyD88 (myeloid differentiation factor 88) adaptor protein leads to a downstream protein kinase cascade that activates the transcription factor NF-κB (nuclear factor kappa-light-chain-enhancer of activated B cells). This drives the transcription of pro-inflammatory cytokines (such as IL-1, IL-6, and TNF-α).
TRIF-Dependent Pathway
Utilised uniquely by TLR3 and endosomal TLR4. Recruitment of the TRIF (TIR domain-containing adaptor-inducing IFN-β factor) adaptor protein leads to the activation of IRFs (Interferon Regulatory Factors). This drives the transcription of Type I Interferons (IFN-α and IFN-β) and promotes dendritic cell maturation.
3. The Inflammatory Response and Cytokine Biology
Inflammation is a coordinated response designed to deliver host defence cells and molecules from the blood directly to the site of infection or tissue damage.
3.1 Clinical Hallmarks of Inflammation
Historically described by five Latin terms:
- Sign 1
Calor & Rubor
(heat & redness)Result from increased vascular diameter (vasodilation) and increased local blood flow.
- Sign 2
Tumor
(swelling / edema)Caused by increased vascular permeability leading to the leakage of fluids and plasma proteins into tissue spaces.
- Sign 3
Dolor
(pain)Caused by chemical mediators stimulating local nerve endings.
- Sign 4
Functio Laesa
(loss of function)Results from the combined tissue swelling and pain.
Leukocyte Extravasation
Leukocyte extravasation into inflamed tissues depends on the sequential expression of adhesion molecules on both leukocytes and vascular endothelial cells, guided by concentration gradients of chemokines (small chemoattractant proteins).
3.2 Cytokine Characteristics and Mechanics
Cytokines are low molecular weight (typically less than 30 kDa), non-immunoglobulin soluble proteins secreted by immune cells to coordinate cellular communication. Unlike hormones, which are produced by specialised glands and act endocrine-style on restricted targets, cytokines are secreted by many widely distributed cells in response to specific stimuli, acting locally or systemically.
Cytokines exhibit four hallmark regulatory properties:
- Property 1
PleiotropyA single cytokine exerts distinct biological activities on different target cells.
- Property 2
RedundancyMultiple different cytokines mediate the same functional outcome.
- Property 3
SynergyThe combined effect of two cytokines is significantly greater than the sum of their individual effects.
- Property 4
AntagonismOne cytokine directly inhibits or counteracts the biological effect of another.
Figure: Pleiotropy vs. Redundancy. Pleiotropy occurs when a single cytokine (Cytokine X) produces distinct effects on different target cells (A, B, C). Redundancy is the converse: multiple distinct cytokines (Cytokine Y, Cytokine Z) converge on the same target cell (D) to produce the same functional outcome (Effect 4).
Signaling Pathways
Cytokines signal through autocrine (acting on the producing cell), paracrine (acting on adjacent cells), or endocrine (entering circulation to act on distant targets) pathways by binding to high-affinity transmembrane receptors.
3.3 Major Cytokine Families
- Family
Interleukins (ILs)Secreted primarily by leukocytes to regulate other leukocytes.
- Family
ChemokinesChemoattractant cytokines defined by four conserved cysteine residues, signaling through G-protein coupled receptors (GPCRs) to direct cell migration.
- Family
Interferons (IFNs)Critical mediators of antiviral defence, cell growth inhibition, and immune activation. Grouped into Type I (IFN-α, IFN-β), Type II (IFN-γ), and Type III.
- Family
TNF FamilyA group of 19 structurally related proteins (including TNF-α and TNF-β) regulating cell survival, differentiation, and apoptosis.
- Family
HematopoietinsCytokines that drive hematopoietic stem cell differentiation, including Colony-Stimulating Factors (CSF: G-CSF, M-CSF, GM-CSF) and Erythropoietin (Epo).
Primary Innate Cytokines
| Cytokine | Major Cellular Sources | Principal Biological Activities |
|---|---|---|
| IL-1 | Monocytes, macrophages, endothelial cells, epithelial cells | Induces inflammation, fever, and liver synthesis of acute-phase proteins |
| IL-6 | Macrophages, endothelial cells, TH2 cells | Induces acute-phase protein synthesis and influences adaptive immunity |
| IL-12 | Macrophages, dendritic cells | Activates NK cells and directs TH1 cell differentiation in adaptive immunity |
| TNF-α | Macrophages, dendritic cells, NK cells, T cells | Primary trigger for systemic inflammation, acute-phase protein synthesis, and neutrophil activation |
| IFN-α | Macrophages, dendritic cells, virus-infected cells | Activates NK cells and upregulates MHC Class I expression on host cells |
| IFN-β | Macrophages, dendritic cells, virus-infected cells | Activates NK cells and upregulates MHC Class I expression on host cells |
4. Adaptive Immunity
Adaptive (acquired) immunity is an evolutionary feature restricted to jawed vertebrates.
4.1 Key Characteristics of Adaptive Immunity
Adaptive immunity displays four key characteristics:
- Feature 1
Antigenic SpecificityThe capacity to distinguish subtle differences among distinct antigens.
- Feature 2
DiversityThe ability to recognise and respond to billions of unique antigenic configurations.
- Feature 3
Immunologic MemoryThe capacity to recall previous encounters with an antigen, resulting in a primary response that transitions into a much faster, larger, and more effective secondary response.
- Feature 4
Self/Non-Self RecognitionThe ability to respond only to foreign molecules while remaining tolerant to self-antigens (self-tolerance).
4.2 Innate vs. Adaptive Immunity: A Comparative Analysis
| Attribute | Innate Immune Response | Adaptive Immune Response |
|---|---|---|
| Specificity | Antigen non-specific; recognises broad conserved patterns (PAMPs) | Highly antigen-specific; recognises unique epitopes |
| Response Time | Rapid (minutes to hours) | Slow (days to weeks for primary response) |
| Diversity | Limited; encoded directly in the germline | Exceptionally high; generated by somatic gene recombination |
| Memory | Absent or low | Present; forms long-lived memory cell populations |
| Major Cell Types | Phagocytes (macrophages, neutrophils, DCs), NK cells | T cells, B cells, professional Antigen-Presenting Cells |
| Evolutionary Origin | Found in all multicellular organisms (vertebrates & invertebrates) | Found strictly in jawed vertebrates |
4.3 Classifications of Acquired Immunity
Adaptive immunity can be acquired naturally or artificially, and is divided into active or passive forms.
Figure: Classification of Acquired Immunity. Adaptive immunity splits into active immunity, where the host's own immune system is activated and undergoes clonal expansion to create memory, and passive immunity, where the host receives preformed antibodies or cells for immediate but temporary protection without memory formation. Each branch further divides into a naturally-acquired and an artificially-acquired route.
Active Immunity
The host's own immune system is activated and undergoes clonal expansion, creating immunological memory:
- Natural Active: Developing immunity following natural exposure to a live pathogen.
- Artificial Active: Developing immunity following exposure to harmless antigens via vaccination.
Passive Immunity
The host receives preformed antibodies or immune cells, providing immediate but temporary protection without activating the host's immune cells or forming memory:
- Natural Passive: Transfer of maternal antibodies across the placenta to the fetus or via breast milk (colostrum) to the infant.
- Artificial Passive: Administration of preformed antibodies or immune serum (such as antivenom or immunoglobulin therapy) to neutralize toxins or pathogens.
5. Cells of the Immune System: Lineage and Differentiation
All mature blood cells develop from self-renewing, pluripotential Hematopoietic Stem Cells (HSCs) in the bone marrow. This developmental process, called hematopoiesis (or haemopoiesis), branches early into two main lineages: the Common Myeloid Progenitor (CMP) and the Common Lymphoid Progenitor (CLP).
Figure: Hematopoiesis. The HSC gives rise to a Multipotent Progenitor, which branches into the myeloid lineage (CMP, in rust) and the lymphoid lineage (CLP, in purple). The CMP further differentiates through the MEP and GMP into red blood cells, platelets, granulocytes, and monocyte-derived macrophages/dendritic cells; the CLP differentiates directly into B cells, T cells, and NK cells.
5.1 The Lymphoid Lineage (CLP Derivatives)
Lymphocytes constitute 20% to 40% of circulating white blood cells; however, 99% reside in lymphoid tissues and organs.
1. B Lymphocytes (B Cells)
- Maturation
SiteArise and mature within the bone marrow of mammals (or the Bursa of Fabricius in birds).
- Receptor
Antigen ReceptorExpress membrane-bound immunoglobulins (antibodies) that directly bind free, unprocessed extracellular antigens.
- Function
Effector FunctionUpon activation and helper T cell signaling, naive B cells proliferate and differentiate into antibody-secreting plasma cells and long-lived memory B cells. B cells also act as professional Antigen-Presenting Cells (APCs).
B Cell Properties
- Surface Ig: Present.
- Complement Receptors: Present.
- Secretory Products: Antibodies and cytokines.
2. T Lymphocytes (T Cells)
- Maturation
SiteArise in the bone marrow but migrate to the thymus to undergo maturation, TCR gene rearrangement, and positive/negative selection.
- Receptor
Antigen ReceptorExpress a membrane-bound T-cell receptor (TCR), a heterodimer composed of either αβ or γδ chains. The TCR can only recognise processed peptide fragments presented on Major Histocompatibility Complex (MHC) molecules of APCs.
| Subset | Marker & MHC Restriction | Function |
|---|---|---|
| T Helper (TH) | CD4; recognises peptides bound to MHC Class II | Differentiates into TH1, TH2, TH17, TREG, and TFH subsets secreting distinct cytokine profiles |
| T Cytotoxic (TC) | CD8; recognises peptides bound to MHC Class I | Differentiates into Cytotoxic T Lymphocytes (CTLs) that eliminate intracellularly infected host cells and tumour cells |
T Cell Properties
- Ratio: Normal CD4+:CD8+ ratio in peripheral blood is approximately 2:1, but can be altered by immunodeficiencies or autoimmune disorders.
- Surface Ig: Absent.
- Secretory Products: Cytokines.
3. Natural Killer (NK) Cells
- Class
ClassificationLarge, granular lymphocytes belonging to the Innate Lymphoid Cell (ILC) family. Unlike B and T cells, they do not express antigen-specific receptors and do not display immunological memory.
- Maturation
SiteMature in the bone marrow; thymus maturation is not required.
- Mechanism
Mode of ActionKill infected, stressed, or malignant host cells in an antigen-non-specific manner by releasing perforin and granzymes.
- Regulation
NK ReceptorsRegulated by a balance of activating and inhibiting receptors (NKRs). Inhibiting receptors recognise self-MHC Class I molecules on healthy host cells. Because viral infection or malignant transformation often downregulates MHC Class I ("missing self"), the inhibitory signal is lost, triggering NK cell degranulation.
Clinical Correlation
Chediak-Higashi syndrome is an autosomal recessive disorder characterised by a lack of functional NK cells.
4. Natural Killer T (NKT) Cells
- Class
ClassificationA distinct lymphocyte subset sharing properties of both T cells and NK cells.
- Receptor
Antigen ReceptorExpress a semi-invariant TCR alongside NK cell markers. Unlike classical T cells, their TCR does not recognise MHC-peptide complexes; instead, it recognises foreign and self glycolipid antigens presented by the MHC Class I-like molecule CD1d.
5.2 The Myeloid Lineage (CMP Derivatives)
1. Granulocytes
Characterised by irregularly shaped, multilobed nuclei (polymorphonuclear) and prominent cytoplasmic granules:
- Cell
Neutrophils (PMNs)- Make up 50% to 70% of circulating WBCs.
- Their granules stain with both acidic and basic dyes.
- Short-lived phagocytes (circulating 7–10 hours before migrating to tissues, where they live only a few days).
- Extravasation Cascade: (1) adhesion to endothelial cells, (2) penetration through endothelial cell junctions, (3) penetration of the vascular basement membrane, (4) migration towards chemotactic signals.
- Cell
Eosinophils- Make up 2% to 5% of WBCs.
- Stain brightly with the acidic dye eosin and possess a bilobed nucleus.
- Active in host defence against protozoan and helminth parasites by releasing highly toxic cationic proteins and ROS into the extracellular environment.
- Cell
Basophils- Make up less than 1% of circulating WBCs.
- Stain with the basic dye methylene blue and possess a lobed nucleus.
- Non-phagocytic; express high-affinity IgE Fc receptors (FcεR). Antigen binding cross-links IgE, triggering degranulation and release of vasoactive amines (histamine, serotonin), prostaglandins, and leukotrienes to initiate allergic responses.
- Cell
Mast Cells- Arise from pluripotent stem cells in the bone marrow but enter circulation in an immature state. They migrate to tissues (mucosal surfaces, skin) where they mature under the influence of c-kit ligand and Stem Cell Factor (SCF).
- Like basophils, contain large amounts of histamine-rich granules and express high-affinity IgE receptors, playing a critical role in allergies and anaphylaxis.
2. Monocytes and Macrophages
Monocytes
Mononuclear phagocytic cells that circulate in the bloodstream for approximately 8 hours, growing in size before migrating into tissues to differentiate into macrophages or dendritic cells.
Macrophages are highly phagocytic cells present in almost all healthy tissues, divided into two distinct developmental origins:
- Origin 1
Inflammatory MacrophagesDifferentiate from recruited blood monocytes during infection or tissue inflammation.
- Origin 2
Tissue-Resident MacrophagesOriginate from embryonic progenitor cells during fetal development. They do not circulate and are self-renewing, performing tissue-specific physiological and homeostatic functions.
| Tissue | Resident Macrophage |
|---|---|
| Brain | Microglia |
| Lung | Alveolar macrophages |
| Liver | Kupffer cells |
| Skin | Langerhans cells |
| Spleen | Red pulp macrophages |
| Bone Marrow | Bone marrow macrophages |
| Lymph Node | Subcapsular sinus macrophages |
3. Dendritic Cells (DCs)
Dendritic cells arise from both myeloid and lymphoid lineages, exhibiting long, membrane-like extensions resembling dendrites.
- Type
Classical Antigen-Presenting DCsCapture antigen in peripheral tissues (by phagocytosis or macropinocytosis), process it, and migrate to secondary lymphoid organs. There, they upregulate co-stimulatory molecules and constitutively express exceptionally high levels of MHC Class II molecules, acting as professional APCs to activate naive TH cells.
- Subtypes
Four Major DC SubtypesLangerhans cells, interstitial dendritic cells, myeloid dendritic cells, and lymphoid dendritic cells.
Follicular Dendritic Cells (FDCs)
- Unlike classical DCs, FDCs do not express MHC Class II and do not present antigens to T cells.
- Located strictly within B-cell follicles of secondary lymphoid organs and belong to a distinct lineage.
- Express high levels of Fc receptors and complement receptors, allowing them to bind and retain intact antigen-antibody complexes on their surface — crucial for B-cell activation, affinity maturation, and somatic hypermutation.
6. Lymphoid Organs: Architecture and Function
The lymphatic system is organized into primary (central) lymphoid organs, where lymphocytes mature, and secondary (peripheral) lymphoid organs, where mature lymphocytes encounter antigens and initiate immune responses.
Figure: Classification of Lymphoid Organs. Primary lymphoid organs (Bone Marrow, Thymus) provide the microenvironment for antigen-independent lymphocyte maturation. Secondary lymphoid organs (Spleen, Lymph Nodes, MALT) capture antigens and support antigen-dependent activation of mature lymphocytes.
6.1 Primary Lymphoid Organs
These organs provide the microenvironment necessary for B-cell and T-cell precursors to mature and acquire their antigen-specific receptors.
Bone Marrow
The primary site of hematopoiesis and B-cell maturation in adult mammals. Prior to birth, hematopoiesis occurs in the fetal liver. In birds, B cells mature in a specialized sac-like dorsal organ called the Bursa of Fabricius. Mammals do not possess a bursa of Fabricius.
Thymus
A flat, bilobed organ situated above the heart, surrounded by a capsule and divided into lobules by connective tissue strands called trabeculae. Each lobule consists of:
- Zone
Outer CortexPacked with immature, rapidly proliferating T-cell precursors (thymocytes) undergoing positive selection.
- Zone
Inner MedullaContains more mature thymocytes undergoing negative selection (to eliminate self-reactive T cells).
After thymic selection, functional, self-tolerant T cells enter the bloodstream and home to secondary lymphoid organs.
6.2 Secondary Lymphoid Organs
These organs are anatomically designed to trap and concentrate foreign antigens, bringing them into contact with migrating, mature lymphocytes.
1. Spleen
The largest secondary lymphoid organ, located in the abdominal cavity. It specializes in trapping blood-borne antigens and is the main site of systemic antibody production. The spleen parenchyma is divided into two distinct regions:
- Region 1
Red PulpComposed of venous sinusoids and splenic cords (Billroth's cords) containing erythrocytes, macrophages, lymphocytes, and granulocytes.
- Macrophages destroy blood-borne pathogens
- Removes worn-out, ruptured, or defective red blood cells and platelets
- Stores up to one-third of the body's platelets
- Serves as a site of hematopoiesis during fetal development
- Region 2
White PulpOrganized lymphoid tissue arranged around central arteries, forming the Periarterial Lymphatic Sheath (PALS):
- The PALS is dominated by T cells.
- Surrounding lymph follicles contain B cells. Upon antigen stimulation, these follicles develop germinal centres where B cells undergo rapid clonal expansion and differentiation into plasma cells.
Figure: Spleen Parenchyma. Red pulp clears defective blood cells, stores platelets, and supports fetal hematopoiesis. White pulp is organized around central arteries into the T-cell-dominated PALS and B-cell-containing follicles; antigen stimulation drives follicles to develop germinal centres, the site of B-cell clonal expansion and plasma cell differentiation.
2. Lymph Nodes
Small, encapsulated, bean-shaped structures (typically less than 1 cm in diameter) distributed along lymphatic vessels throughout the body. They act as filters for lymph to trap tissue-derived antigens:
| Region | Composition |
|---|---|
| Cortex | Outer region; lymphoid follicles containing primarily B cells, FDCs, and follicular helper T cells. Primary follicles contain naive B cells; secondary follicles contain germinal centres. |
| Paracortex | Middle region; dominated by T lymphocytes and interdigitating dendritic cells presenting captured antigens. |
| Medulla | Innermost region; contains cords of antibody-secreting plasma cells, macrophages, and lymphocytes arranged around lymphatic sinuses. |
Lymph Flow
Lymph enters via multiple afferent lymphatic vessels, filters slowly through reticular fibers, and exits through a single efferent lymphatic vessel.
3. Mucosa-Associated Lymphoid Tissue (MALT)
Organized lymphoid structures situated at mucosal surfaces of the respiratory, digestive, and genitourinary tracts, which are major entry ports for pathogens. Key components include:
- Component
BALTBronchus-Associated Lymphoid Tissue.
- Component
GALTGut-Associated Lymphoid Tissue. GALT includes the tonsils and adenoids, and Peyer's patches.
Peyer's Patches
Specialised, unencapsulated lymphoid follicles situated in the submucosa of the small intestine. They play a vital role in sampling luminal pathogens and generating mucosal IgE and IgA secretory antibody responses.
7. Innate and Adaptive Immunity Are Interdependent
Innate and adaptive immune systems do not function in isolation. They are highly cooperative and interdependent.
Figure: Innate-Adaptive Feedback Loop. The innate system instructs the adaptive response through antigen presentation and co-stimulatory signals, while the adaptive system, once activated, enhances innate effector mechanisms through cytokines and antibody-mediated targeting.
Innate Instructs Adaptive
Phagocytic cells (such as dendritic cells and macrophages) capture, process, and present antigens in the context of MHC Class I or II. PRR activation on these APCs drives the expression of critical co-stimulatory ligands (such as CD80/CD86) and polarizing cytokines (such as IL-12), guiding T-cell differentiation.
Adaptive Enhances Innate
Activated T helper cells produce immunoregulatory cytokines (such as IFN-γ) that activate macrophages, greatly enhancing their ability to kill intracellular pathogens and present antigens. Antibodies produced by B cells coat pathogens, targeting them for destruction by innate mechanisms such as the complement cascade or Fc-receptor-mediated phagocytosis.
In this lesson
LessonStep 8 of 28

